Innovating and Partnering: Menten AI’s March Conference Recap

Menten AI has been busy attending conferences this March. Our CEO, Hans Melo, recently represented our company at the NextGen Biomed conference in London as well as the BIO-Europe Spring conference in Milan . He showcased our groundbreaking work in cyclic peptide drug design. The presentations highlighted our latest advancements, strategic partnerships, and the potential of our platform to revolutionize therapeutic development. These opportunities allowed us to connect with industry leaders and researchers, reinforcing our commitment to driving the future of peptide-based medicines.

We’re constantly attending industry conferences and would love to connect! Stay tuned on LinkedIn to see where we’ll be and explore partnership opportunities. Let’s collaborate!